Vertex drops Moderna-partnered inhaled cystic fibrosis candidate after unresolved tolerability issues

After pausing a trial for a Moderna-partnered cystic fibrosis candidate due to subpar tolerability, Vertex Pharmaceuticals has now decided to discontinue the pr...